{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:53:53Z","timestamp":1783727633178,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.jbspin.2007.12.009","type":"journal-article","created":{"date-parts":[[2008,8,7]],"date-time":"2008-08-07T05:09:36Z","timestamp":1218085776000},"page":"737-739","source":"Crossref","is-referenced-by-count":51,"title":["Infliximab-induced hepatitis: absence of cross-toxicity with etanercept"],"prefix":"10.1016","volume":"75","author":[{"given":"G\u00e9rard","family":"Thi\u00e9fin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Morelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Heurgu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Daniele","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Eschard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2007.12.009_bib1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2007.12.009_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2007.12.009_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4065\/76.1.84","article-title":"Infliximab-associated reversible cholestatic liver disease","volume":"76","author":"Menghini","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2007.12.009_bib4","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/1529-0131(200108)44:8<1966::AID-ART339>3.0.CO;2-3","article-title":"Hepatitis with interface inflammation and IgG, IgM, and IgA anti-doubled-stranded DNA antibodies following infliximab therapy: comment on the article by Charles, et al","volume":"44","author":"Saleem","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2007.12.009_bib5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","author":"Germano","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2007.12.009_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/00044011-200626110-00008","article-title":"Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis","volume":"26","author":"Ierardi","year":"2006","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.jbspin.2007.12.009_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","article-title":"Serious liver disease induced by infliximab","volume":"26","author":"Tobon","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2007.12.009_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10067-006-0253-y","article-title":"Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab","volume":"26","author":"Garcia Aparicio","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2007.12.009_bib9","unstructured":"FDA Briefing Document. Arthritis Advisory Committee. Available from:http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/transcripts\/3930T1.htm."},{"key":"10.1016\/j.jbspin.2007.12.009_bib10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/bmj.330.7493.716","article-title":"Recent developments in the use of biologics in psoriasis and autoimmune disorders. The role of autoantibodies","volume":"330","author":"Rott","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2007.12.009_bib11","first-page":"1098","article-title":"The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis","volume":"31","author":"Hansen","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jbspin.2007.12.009_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drudis.2006.11.013","article-title":"Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease","volume":"12","author":"Kooloos","year":"2007","journal-title":"Drug Discov Today"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X08001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X08001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T11:55:00Z","timestamp":1545825300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X08001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1297319X08001449"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2007.12.009","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}